|
Volumn 80, Issue 3, 2001, Pages B35-B37
|
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DNA;
DOXORUBICIN;
ETOPOSIDE;
PREDNISONE;
VINCRISTINE;
CHROMOSOME 12Q;
CHROMOSOME 13Q;
CHROMOSOME 18Q;
CHROMOSOME 4Q;
CHROMOSOME 6Q;
CHROMOSOME 7Q;
CHROMOSOME ABERRATION;
CLINICAL TRIAL;
COMPARATIVE GENOMIC HYBRIDIZATION;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOGENETICS;
GENOME;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MINIMAL RESIDUAL DISEASE;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROGNOSIS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHROMOSOME ABERRATIONS;
CHROMOSOMES, HUMAN;
CYCLOPHOSPHAMIDE;
DNA, NEOPLASM;
DOXORUBICIN;
ETOPOSIDE;
HUMANS;
LIFE TABLES;
LYMPHOMA, HIGH-GRADE;
METAPHASE;
NUCLEIC ACID HYBRIDIZATION;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PREDNISOLONE;
PREDNISONE;
PROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
VINCRISTINE;
|
EID: 0035195994
PISSN: 09458077
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (13)
|